Experimental antiviral proves effective in halting spread and damage of COVID-19
Scientists from the United States National Institutes of Health and the University of Plymouth showed that an experimental antiviral drug can significantly decrease levels of the virus causing COVID-19 and the damage it causes in the lungs
Scientists make step forward in development of COVID-19 animal vaccines
The Vaccine Group, a spinout company from the University of Plymouth, has revealed its first two possible vaccines to tackle COVID-19 in animals have proved successful in pre-animal trial laboratory testing
Could self-disseminating vaccines cut off emerging infectious diseases at source?
Plymouth University news: An expert reviews identifies state of the art of self-disseminating vaccines as a potentially powerful strategy to circumvent emerging infectious diseases at the animal source before their establishment as the next human pandemic